Your Comments On...

MedImmune Asks For Right to Sue

A lawyer for MedImmune Inc. asked the Supreme Court yesterday to let the company sue to overturn a patent owned by Genentech Inc. on a component of MedImmune's blockbuster drug Synagis, even though MedImmune is paying royalties to use it.

By Charles Lane

© 2006 The Washington Post Company